Daewon Pharma

Focus: Daewon Pharma is a Korean-based small molecule pharmaceutical company focused on metabolic, respiratory, cardiovascular, and gastroenterology diseases. The company operates from Hwaseong, Korea with a diversified pipeline spanning multiple therapeutic areas.

Metabolic Diseases Respiratory Cardiovascular Nephrology

Profile data last refreshed 2d ago · AI intelligence enriched 2w ago

Open Jobs

About Daewon Pharma

AI assessmentNot Hiring

No open roles listed right now. Follow Daewon Pharma to get notified when they start hiring — the background below is worth knowing for when they do.

Why Work Here

Data completeness

1/9 — Limited

Company HealthStrong

Pipeline

Late-stage

19 Phase 3+

LOE Risk

Protected

No near-term cliffs

Hiring

0 open

Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.

Pipeline & Clinical Trials

Age: 20-40years

Healthy

N/A

Clinical Trials (1)

NCT02384720Study of Freefol-MCT PKPD in Healthy Volunteers

N/A

Help build intelligence for Daewon Pharma

No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.

Share Interview Share Compensation

Data Sources

Drug label: DailyMed / FDA
Clinical trials: ClinicalTrials.gov
Patent data: FDA Orange Book
Spending data: CMS Medicare

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.

Diversified pipeline with 30 programs across Phase 1-4, including 5 Phase 3 programs offering multiple clinical development career paths
Established presence in high-value therapeutic areas (cardiovascular, metabolic disease, respiratory) with multiple late-stage programs approaching regulatory milestones
Portfolio includes both novel DW-series compounds and optimized formulations of known actives, offering exposure to both innovative and lifecycle management strategies

Watch Out For

No active job openings listed and limited public visibility into company size, financials, or growth trajectory, suggesting limited near-term hiring
Sparse public information on revenue, funding, R&D spend, and financial stability makes long-term career security assessment difficult

Generated by Claude from Daewon Pharma's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.

Omega-3 acid ethyl esters

Patients With Hypertriglyceridemia

N/A

Clinical Trials (1)

NCT01712867The Effect of Phytosterol Esters of Omega-3 (Vayarol) Versus Omega-3 Acids Ethyl Esters in Reducing Triglyceride Levels

N/A

DW1809-T2

Osteoarthritis

Phase 1

Clinical Trials (1)

NCT05214690A Phase 1 Clinical Trial to Evaluate the Safety and Pharmacokinetic Characteristics of DW1809-T2

Phase 1

DW4421

GERD (Gastroesophageal Reflux Disease)

Phase 1

Clinical Trials (1)

NCT07364838Study to Evaluate the Effect of Food on the Pharmacokinetics and Pharmacodynamics Characteristics in Healthy Adult Volunteers

Phase 1

DW4421-T1

Healthy Adult Volunteer

Phase 1

Clinical Trials (1)

NCT07364851A Phase 1 Clinical Trial to Evaluate the Safety and Pharmacokinetics of DW4421-T1 and DW4421S-T1 in Healthy Adult Volunteers

Phase 1

Telmisartan

Hypertension and Dyslipidemia

Phase 1

Clinical Trials (1)

NCT02933658Study of Multiple Oral Dosing to Evaluate the Safety and the Pharmacokinetic Drug-drug Interaction of Telmisartan/Amlodipine and Rosuvastatin in Healthy Male Volunteers

Phase 1

Tramadol hydrochloride/Acetaminophen Tab.

Low Back Pain

Phase 1

Clinical Trials (1)

NCT01776515Phase 3 Study of Tramadol Hydrochloride/Acetaminophen SR Tab. & Tramadol Hydrochloride/Acetaminophen Tab. in Low Back Pain Patients

Phase 1

Megace 800mg/20ml

Healthy

Phase 1

Clinical Trials (1)

NCT01589562Phase 1 Study of Daewon-ES(B) & Megace in Healthy Male Volunteers Under Fed Condition

Phase 1

DW5124

Mixed Dyslipidemia

Phase 1

Clinical Trials (1)

NCT07319559Clinical Trial to Evaluate the Safety, Pharmacokinetic Characteristics of DW5124 and DW5124-R, and the Effect of Food on DW5124 in Healthy Adult Volunteers

Phase 1

DW1809

Osteoarthritis

Phase 1

Clinical Trials (1)

NCT05214677A Phase 1 Clinical Trial to Evaluate the Safety and Pharmacokinetic Characteristics of DW1809

Phase 1

DW4421

Healthy Adult Volunteer

Phase 1

Clinical Trials (1)

NCT07364877A Phase 1 Clinical Trial to Evaluate the Safety and Pharmacokinetics of DW4421 and DW4421S in Healthy Adult Volunteers

Phase 1

DW4421

Healthy Adult Volunteers

Phase 1

Clinical Trials (1)

NCT07382661Drug-Drug Interaction Between DW4421 and Amoxicillin/Clarithromycin

Phase 1

DW4421

Healthy Adult

Phase 1

Clinical Trials (1)

NCT07343245A Phase 1 Clinical Trial to Evaluate the Safety and DDI of DW4421 and 3 NSAIDs

Phase 1

DW-1021

Healthy Volunteers

Phase 1

Clinical Trials (1)

NCT07060209Food Effect on PK of DW-1021 (Pelubiprofen 45 mg / Tramadol 45.9 mg) in Healthy Adults

Phase 1

DW1903

Gastritis

Phase 1

Clinical Trials (1)

NCT05155072Clinical Trial to Evaluate the Safety and Pharmacokinetic/Pharmacodynamic Characteristics of DW1903

Phase 1

DW5221

Apetite Stimulants

Phase 1

Clinical Trials (1)

NCT06147908Clinical Trial to Evaluate the Pharmacokinetic Characteristics of DW5221 and DW5221-R

Phase 1

combination drug: DW330SR, DW1030

Healthy

Phase 1

Clinical Trials (1)

NCT02380976Phase 1 Clinical Trial of DW340 and DW330SR + DW1030 Co-administration in Healthy Male Volunteers

Phase 1

DW-0920

Healthy

Phase 1

Clinical Trials (1)

NCT01606059Phase 1 Study of DW-0919 & DW-0920 in Healthy Male Volunteers Under Fasting Condition

Phase 1

DW-1021

Healthy Volunteer

Phase 1

Clinical Trials (1)

NCT07032558Comparison of DW-1021 and Separate Doses of Pelubi CR and Zytram CR Under Fasting Conditions

Phase 1

DW5524

Healthy Adult

Phase 1

Clinical Trials (1)

NCT07349589Evaluate the Safety, Tolerability and Pharmacokinetics of DW5524 in Healthy Adult Volunteers

Phase 1

pelubiprofen

Healthy

Phase 1

Clinical Trials (1)

NCT01776697Phase 1 Study to Compare the Pharmacokinetic Characteristics and Food Effect of Pelubiprofen (30mg) Tablet IR TID and Pelubiprofen SR (as a Pelubiprofen 90 mg) Tablet QD in Healthy Subjects

Phase 1

DW330SR 45mg

Healthy

Phase 1

Clinical Trials (1)

NCT02071381Phase 1 Study of DDI Between DW330SR and DW1030 in Healthy Male Subjects

Phase 1

Pelubiprofen IR

Healthy Males

Phase 1

Clinical Trials (1)

NCT01870102Phase 1 Study to Compare the Pharmacokinetic Characteristics and Food Effect of Pelubiprofen (30mg) Tablet IR and Pelubiprofen SR (as a Pelubiprofen 45 mg) Tablet in Healthy Subjects

Phase 1

DW340

Acute Low Back Pain

Phase 2

Clinical Trials (1)

NCT03424707A Study to Evaluate the Efficacy and Safety of Fixed Dose Combination of DW340 in Patients With Acute Low Back Pain

Phase 2

DW-3101_150mg

Acute and Chronic Gastric Inflammation Patients

Phase 2

Clinical Trials (1)

NCT02386007Phase 2a Study to Evaluate Optimum Dosage and Stability of DW-3101 in Gastric Inflammation Patients

Phase 2

DW4902 Placebo

Myoma of Uterus

Phase 2

Clinical Trials (1)

NCT07319520Clinical Trial to Evaluate the Efficacy and Safety of DW4902

Phase 2

DW-3102

Hypercholesterolemia

Phase 2

Clinical Trials (1)

NCT02368613A Clinical Trial for Evaluation of Adequate Dose and Safety of DW-3102 in Hypercholesterolemia Patients

Phase 2

Pelubiprofen 45mg

Primary Dysmenorrhea

Phase 3

Clinical Trials (1)

NCT04541134Phase 3 Clinical Trial to Evaluate of the Efficacy and Safety of DW9801 in Patients With Primary Dysmenorrhea

Phase 3

DW1903

Gastritis Acute

Phase 3

Clinical Trials (1)

NCT05163756To Evaluate the Efficacy and Safety of DW1903 in Acute and Chronic Gastritis Patient

Phase 3

DW5121

Acute Bronchitis

Phase 3

Clinical Trials (1)

NCT07093697A Study to Evaluate the Efficacy and Safety of DW5121 Compared to DW51211 and DW51212

Phase 3

DW1601

Acute Bronchitis

Phase 3

Clinical Trials (1)

NCT04260555Clinical Trial to Evaluate the Efficacy and Safety of 'DW1601' in Acute Bronchitis

Phase 3

DW-0929

Hypercholesterolemia

Phase 3

Clinical Trials (1)

NCT02390375Phase 3 Study to Evaluate the Efficacy and Safety of the DW0929 in Patients With Primary Hypercholesterolemia

Phase 3

Test

Gastritis Acute

Phase 3

Clinical Trials (1)

NCT03443804To Evaluate the Efficacy and Safety of DW-1401 in Acute and Chronic Gastritis Patients

Phase 3

Pelubiprofen

Acute Upper Respiratory Infection

Phase 3

Clinical Trials (1)

NCT01779271Phase 3 Study of Pelubiprofen & Loxoprofen in Patients With Upper Respiratory Tract Infection

Phase 3

pelubiprofen 45mg

Acute Traumatic Injury

Phase 3

Clinical Trials (1)

NCT03874247Clinical Trial to Evaluate the Efficacy and Safety of 'Pelubiprofen Controlled Released Tab.' in Acute Traumatic Injury

Phase 3

DW-1030

Acute Back Pain

Phase 3

Clinical Trials (1)

NCT02040415Phase 3 Study to Evaluate the Efficacy and Safety of DW-1030 and Eperisone HCl in Acute Back Pain Patients

Phase 3

Ezetimibe/Atorvastatin 10/5 mg

Hypercholesterolemia, Dyslipidemia

Phase 3

Clinical Trials (1)

NCT05970679Clinical Trial to Evaluate the Efficacy and Safety of DW1125 and DW1125A

Phase 3

DW-330SR2

Chronic Back Pain

Phase 3

Clinical Trials (1)

NCT02375633Phase 3 Study of DW-330SR2 and Pelubiprofen in Chronic Back Pain Patients

Phase 3

DW5421A

Primary Hypercholesterolemia

Phase 3

Clinical Trials (1)

NCT07444762Clinical Trial to Evaluate the Efficacy and Safety of Combination Therapy of DW5421A/DW5421B Compared to Monotherapy of DW5421A

Phase 3

GLA5PR GLARS-NF1

Pain of Mononeuropathy

Phase 3

Clinical Trials (1)

NCT03221907Clinical Trial to Evaluate the Efficacy and Safety of 'GLA5PR GLARS-NF1 Tab.' in Peripheral Neuropathic Pain

Phase 3

Experimental

Perennial Allergic Rhinitis Accompanied by Asthma

Phase 3

Clinical Trials (1)

NCT07168473Study to Evaluate the Efficacy and Safety of DW1807 in Perennial Allergic Rhinitis Patients With Asthma

Phase 3

Telmisartan + Amlodipine + Rosuvastatin

Hypertension

Phase 3

Clinical Trials (1)

NCT03210532Evaluate the Efficacy and Safety of Combination Treatment With DW1501-R1+DW1501-R2 Versus DW1501-R1 or DW1501-R2+DW1501-R3 in Patients With Hypertension and Dyslipidemia

Phase 3

DW1026C1

Type 2 Diabetes

Phase 3

Clinical Trials (1)

NCT07076056Clinical Trial to Evaluate the Efficacy and Safety of DW1026C1 or DW1026C2

Phase 3

Pelubiprofen 30 mg

Pelubiprofen

Phase 3

Clinical Trials (1)

NCT01781702Phase 3 Study of Pelubiprofen Tab. & Celebrex Cap. in Rheumatoid Arthritis Patients

Phase 3

DWKH

Respiratory Infection

Phase 3

Clinical Trials (1)

NCT05683951Clinical Trial to Evaluate the Efficacy and Safety of DWKH

Phase 3

Tramadol hydrochloride/Acetaminophen Tab.

Acute Toothache Patients Above Moderate Pain After Teeth Extraction Surgery

Phase 3

Clinical Trials (1)

NCT01920386Phase 3 Study of Tramadol Hydrochloride/Acetaminophen SR Tab. & Tramadol Hydrochloride/Acetaminophen Tab. in Acute Toothache Patients After Teeth Extraction Surgery

Phase 3

Choline fenofibrate

Dyslipidemia

Phase 4

Clinical Trials (1)

NCT05365425Choline Fenofibrate and Carotid Atherosclerosis in Patients With Type 2 Diabetes and Combined Dyslipidemia

Phase 4

Renamezin capsule

Chronic Renal Failure

Phase 4

Clinical Trials (1)

NCT02681952A Multicenter, Randomized, Open-labeled, Cross-over, Active-controlled, Phase IV Clinical Trial to Evaluate the Preference of Formulation and the Efficacy and Safety of Renamezin and Kremezin in Pre-dialysis Patients With Chronic Renal Failure

Phase 4

Combination therapy

ASCVD

Phase 4

Clinical Trials (1)

NCT06767774Comparison of Pitavastatin Plus Ezetimibe Versus High-Intensity Statin Therapy on Risk of New-Onset Diabetes Mellitus

Phase 4

Pelubiprofen CR 45mg tab.

Osteoarthritis of Knee

Phase 4

Clinical Trials (1)

NCT02682524Phase IV Clinical Trial to Evaluate the Efficacy and Safety of PlbCR and Aceclofenac in the Treatment of Patients With Osteoarthritis of the Knee

Phase 4